Illumina CEO DeSouza Resigns After Facing Pressure From Icahn
Illumina Inc.’s board accepted the resignation of Chief Executive Officer Francis deSouza, effective Sunday, according to a statement.
2023-06-11 20:50
Support for ESG Shareholder Proposals Plummets Amid GOP Backlash
Investor support for environmental and social shareholder proposals slumped to the lowest in six years amid the Republican
2023-06-09 20:16
Astra Enters Into $2 Billion-Plus Pact With UK Biotech Quell
AstraZeneca Plc entered a collaboration with UK biotech Quell Therapeutics potentially worth more than $2 billion to develop
2023-06-09 15:26
Binance.US suspends US dollar deposits after crackdown by regulators
Crypto exchange Binance.US said on Thursday it is suspending U.S. dollar deposits and that its banking partners are
2023-06-09 14:16
Novartis’s Sandoz Sees Pipeline Adding $3 Billion Sales by 2028
Novartis AG’s generic-drug unit Sandoz could add $3 billion in sales over the next five years from its
2023-06-08 13:48
Schroders Seeks a Crypto Custodian for Digital-Asset Push
Schroders Plc is seeking to hire a third-party custodian for cryptocurrencies, people with knowledge of the matter said,
2023-06-08 01:56
Leftist Colombia Leader Delivers the Paralysis Markets Want
Gustavo Petro’s dream of becoming an inspirational leftist leader who would jettison Colombia’s conservative economic orthodoxy is fading
2023-06-08 01:16
Zuckerberg Is Helping to Propel Chicago’s Biotech Ambitions
For about a year, Northwestern University professor Shana Kelley and a group of more than 20 Chicago scientists
2023-06-07 22:51
Drug Safety Fears Spur Pentagon Plan to Test Widely Used Medicines
US military officials are so concerned about the quality of generic drugs that the Department of Defense is
2023-06-07 20:46
Contaminated Drugs, Shredded Papers: US FDA Uncovers Failures in India Pharma Factories
US inspectors have in recent months uncovered wide-ranging lapses at factories run by some of India’s biggest pharmaceutical
2023-06-07 13:59
Ozempic is taking China by storm. Drugmakers are scrambling to boost supplies
Ozempic, originally a medication for treating diabetes, is in high demand worldwide with celebrities and social media users touting it as a miracle drug for weight loss. Now the frenzy is sweeping through China, where being "wafer thin" is a prevailing beauty standard, leading to shortages in the country.
2023-06-07 10:19
AstraZeneca’s Japan Partner to Go Solo on Future Cancer Drugs
When Japanese pharmaceutical company Daiichi Sankyo Co. discovered a groundbreaking cancer treatment, it turned to bigger Western drugmaker
2023-06-07 05:27